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Objective: Controversy persists with regard to the treatment of patients with 
aortic atresia. Staged reconstructive op rations and pr imary transplanta- 
tion have been advocated as treatment strategies, but in many instances no 
treatment is undertaken. A multi- institutional study was undertaken fi~r 
the purpose of characterizing this challenging patient group, comparing the 
prevalence and outcomes of the various treatment strategies, and identify- 
ing potential predictors of success or failure with each. Methods and results: 
A total of 323 neonates with aortic atresia were entered into a 21-institution 
prospective, nonrandomized study between January 1, 1994, and January 1, 
1997. Three protocols were used, nonexclusively in many institutions: (1) 
staged reconstructive surgery with initial pall iation by a Norwood proce- 
dure and eventual Fontan operation, (2) heart transplantat ion as initial 
definitive therapy, and (3) nonsurgical management. Analysis was based on 
initial protocol assignment: staged reconstructive surgery in 253 patients, 
heart transplantat ion i 49 patients, and nonsurgical management in 21 
patients. For all patients initially entered into the 2 surgical treatment 
protocols, survival at 1, 3, 12, 24, and 36 months after entry was 67%, 59%, 
52%, 51%, and 50%, respectively. A multivariable analysis found incremen- 
tal risk factors for death at any time after entry to be lower birth weight 
(P = .04), associated noncardiac anomaly (P = .007), and entry into the 
nonsurgical protocol (P < .0001) or the staged reconstructive surgery 
protocol (P = .03). Four institutions had higher survival statistics; 2 used 
a heart transplantat ion protocol and 2 used a staged reconstructive surgery 
protocol. For  the 113 patients treated at these 4 institutions, survival at 1, 
3, 12, 24, and 36 months after entry was 77%, 70%, 64%, 62%, and 61%, 
respectively. Survival among the 4 institutions was similar (P = 0.1). 
Conclusions: Among patients with aortic atresia, other features of cardiac 
structure including aortic size, degree of left ventricular hypoplasia, and 
degree of mitral hypoplasia or atresia are not predictive of survival from 2 
surgical protocols. The highest survival was achieved with either treatment 
strategy at institutions strongly committed to the use of one or the other 
surgical management protocol. (J Thorac Cardiovasc Surg 1998;116:417-31) 
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A ortic valve atresia is the anatomic hal lmark of the largest group of neonates born with a cardiac 
mal format ion with single ventricle physiology. Of all 
babies considered to have hypoplastic left heart  
syndrome, two thirds or more  have aort ic valve 
atres ia J '  2 In the absence of specific therapy, physi- 
ologic constr ict ion of the ductus arteriosus after 
birth leads invariably to death from systemic hypo- 
perfusion, coronary insufficiency, or congestive 
heart  failure. T reatment  strategies have evolved on 
the basis of either reconstructive surgery, along the 
lines developed by Norwood and others, 3' 4 or car- 
diac replacement,  as p ioneered by Bailey and oth- 
ers.S, 6 There have been numerous reports of en- 
couraging and improving outcomes with one or the 
other t reatment  strategy from several institutions. 7-9 
Nonetheless,  the relative efficacy of these 2 treat- 
ment strategies remains a matter  of speculation, and 
in many instances babies with aortic atresia are 
al lowed to die of the predictable natural  history of 
the disease without therapeut ic  intervention. 
A study of outcomes in a large group of neonates 
with aortic atresia could be of value to per inatolo-  
gists, neonatologists,  pediatr ic  ardiologists and sur- 
geons, and others involved in the support  and 
management  of famil ies with fetuses and neonates 
with aortic atresia. A mult i - inst itut ional study was 
begun to provide such information. Analysis is cen- 
tered around the intent ion to treat (or not treat) 
with a protocol  based on (1) staged reconstructive 
surgery (Norwood procedure  followed ult imately by 
Fontan-type reconstruct ion),  (2) heart transplanta-  
tion as initial definitive therapy, or (3) no surgical 
treatment.  Among the goals of the study were to 
define the spectrum of cardiac morphology associ- 
ated with aortic valve atresia, to define the spectrum 
of surgical approaches currently used and their 
respective outcomes, and to undertake analyses 
leading to inferences concerning the impact of pa- 
t ient characterist ics and treatment strategies on 
outcome. In this initial report  of the Congenital  
Heart  Surgeons Society Mult i - Inst itut ional  Study, 
analysis is strictly l imited to those patients with 
aortic valve atresia (a database has been simulta- 
neously, generated for pat ients with aort ic valve 
stenosis and associated left heart obstructive le- 
sions), and considerat ion of outcomes is l imited to 
determinat ion of in termediate- term survival. 
Patients and methods 
Patients. Between January 1, 1994, and January 1, 
1997, 323 neonates (age < 30 days) with aortic valve 
Table I. The spectrum of" cardiac anomalies" 
associated with aortic valve atresia in 323 patients' 
(CHSS: 1994-1997) 
Associated cardiac anomaly 
Total deaths 
~% 
CL 
No. % (%) 
Position cardiac anomaly 
Dextrocardia 1 0 0 0-85 
Atrial anomalies 
Intact atrial septum 13 8 62 43-77 
Left juxtaposition of atrial ap- 1 1 100 15-100 
pendages 
Cortriatriatum dexter 1 1 100 15-100 
Anomalies of right ventricutar out- 
flow 
Bicuspid pulmonary valve 4 2 50 18-82 
Pulmonary valve stenosis (mild) 3 1 33 4-76 
Anomalies of coronary circulation 
LV-coronary artery fistula 8 5 62 38-83 
Single coronary orifice 4 4 100 62-100 
LAD arising from RCA 1 (/ 0 0-85 
Origin of CCX from RPA 1 1 100 15-100 
Cardiac rhythm disturbance 
Wolff-Parkinson-White syndrome 1 0 0 0-85 
Anomalies of the aorta 
Aberrant origin of right subclavian 11 1 9 1-28 
artery 
interrupted aortic arch 1 0 0 0-85 
Unusual aortic branching pattern 1 0 0 0-85 
Aneurysm of transverse arch and 1 1 100 I5-100 
descending thoracic aorta 
Right aortic arch passing retro- 1 1 100 15-100 
esophageally to left-sided e- 
scending thoracic aorta 
Anomalies of systemic venous con- 
nection 
Bilateral SVC 28 11 39 29-51 
Unroofed coronary sinus* 5 4 80 47-97 
Left SVC to left atrium 1 0 0 0-85 
Left atrium to systemic venous 4 2 50 18-82 
channels? 
Anomalies of pulmonary venous 
connection/drainage 
Partial:) 9 3 33 15-56 
Total§ 3 2 67 24-96 
Aortopulmonary collaterals 1 1 100 15-100 
LV,, Left ventricle; LAD, left anterior descending; RCA, right coronary 
artmy; CCX,, circumflex coronary artery; RPA, right pulmonary artery; 
SVC, superior vena cava; CL, confidence limits. 
*Intact atrial septum in3. 
?Intact atrial septuln i all. 
~Intact atrial septum in1. 
§Intact atrial scptum in 1. 
atresia were entered into a prospective study in 21 insti- 
tutions (Appendix A). Two thirds of the patients were 
aged 2 days or less at admission and 90% were aged 7 days 
or less. The diagnosis of aortic valve atresia was made in 
all instances by 2-dimensional echocardiography. 
Follow-up. The physician, family, or guardian of each 
patient not known to be dead was contacted each year 
since the beginning of the study. The most recent fol- 
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Fig. 1. Non-risk-adjusted survival and hazard function for death for all 323 patients in the study. A, Survival 
after entry (at time zero). Each circle" represents an actual death, positioned at the time of death along thc 
horizonal axis and actuarially along the vertical axis. The vertical bars depict _+ 1 standard error. The 
numbers indicate the number of patients remaining at risk at the time of the estimate. The solid line is the 
parametric estimate of survival, and the clashed lines enclose the 70% confidence intervals. B, Hazard 
function tor death. 
tow-up was conducted from January through March 
1997. At that time, 165 patients were known to be dead. 
During the 1997 follow-up, 149 of the 158 patients not 
known to be dead were successfully traced. Seven 
additional patients have follow-up through 1996. Only 2 
patients not known to be dead have no follow-up since 
the time of hospital discharge. Median follow-up time 
for survivors is 20 months, range 1.1 to 38 months; 
4 2 0 Jacobs et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
September 1998 
Tab le  I I .  The spectrum of noncardiac anomalies 
associated with aortic valve atresia in 323 patients 
(CHSS; 1994-1997) 
Total deaths 
70% 
Associated noncardiac anomaly n No. % CL (%) 
Turner's yndrome 7 6 86 59-98 
Atagille's yndrome 1 1 100 15-100 
Chromosome 15 abnormality 1 1 100 15-100 
Charge association 1 1 100 15-100 
Langer-Giedion syndrome 1 1 100 15-100 
DiGeorge syndrome 1 1 100 15-100 
Cystic fibrosis 1 1 100 15-100 
Microcephaly 3 2 67 24-96 
Severe diffuse CNS dysfunction 1 1 100 15-100 
Unspecified CNS abnormality 1 1 100 15-100 
Tracheoesophageal fistula with 2 2 100 39-100 
esophageal tresia 
Imperforate anus 1 1 100 15-100 
CNS, Central nervous system; CL, confidence limits. 
mean follow-up time for survivors is 21 + 9.6 months 
(standard deviation). 
Morphology. Estimates of left ventricular size and of 
the structure and patency of the mitral valve were ob- 
tained from echocardiographic reports from the partici- 
pating institutions. Information regarding associated car- 
diac anomalies and size of the ascending aorta were 
obtained from echocardiographic and operative reports. 
Protocols. Each patient was entered into 1 of 3 proto- 
cols based on initial intention to treat at the participating 
institution. Thus all patients listed for heart transplanta- 
tion were considered to have entered the heart transplan- 
tation protocol. All patients managed with intent to 
perform an initial palliative reconstructive operation were 
considered to have entered the staged reconstructive 
surgery protocol. Patients who entered into neither surgi- 
cal treatment protocol were considered to have entered a 
protocol of nonsurgical management. Analysis was under- 
taken in relation to intention to treat (initial protocol 
assignment). Inasmuch as there were a few instances of 
crossover (from nonsurgical management to either of the 
treatment protocols or from one surgical treatment pro- 
tocol to the other), analysis was subsequently undertaken 
with respect o the event of either Norwood procedure or 
heart transplant operation. 
Data collection and analyses. Copies of all hospital 
documents were sent to the Data and Analysis Center at 
the University of Alabama at Birmingham. The data were 
abstracted into computer files, and these and the copies of 
the hospital documents were retained in confidential 
storage. Numerous tabulations, contingency tables, and 
life table analyses (Kaptan-Meier method) were made. 
Timc-related freedom from death or other outcome 
events, and the hazard function, were also computed 
parametrically. Numerous multivariable analyses were 
made in the time-related hazard function regression do- 
main1°; other regression models were used when indi- 
Tab le  I I I .  Distribution of patients (n = 323) by 
institution and by initial protocol assignment (CHS& 
1994-1997) 
Institution n 
Protocol 
No Staged 
treatment reconstruction Transplant 
No. % No. % No. % 
R 36 3 8 33 92 
H 20 1 5 19 95 
C 11 8 73 3 27 
N 56 56 100 
J 51 51 100 
P 12 12 100 
F 11 11 100 
D 9 9 100 
K 5 5 100 
S 3 3 100 
U 4 4 100 
G 3 3 100 
A 2 2 100 
T 2 2 100 
B 1 1 100 
O 15 2 13 
E 14 3 21 
I 24 23 96 
M 5 4 80 
L 25 3 12 1 4 
Q 14 1 7 11 79 
Total 323 21 7 253 78 
13 87 
11 79 
1 4 
1 20 
21 84 
2 14 
49 16 
cated. All continuous variables were examined as contin- 
uous variables (not polytomized). Interaction terms were 
sought in all multivariable analyses: in equations of this 
paper, these may be thought of as terms (variables) that 
are active or inactive only in certain specified relations 
with other variables. Variables with a P value < .1 were 
retained in the final equation. Variables used in the 
multivariable analyses and incremental risk factors for 
death at any time after entry are listed in Appendix B. 
To estimate the proportion of neonates entering each 
of the two surgical protocols that will achieve definitive 
repair, a Competing Risks of Events Analysis was per- 
formed. 11 The mutually exclusive definitive states after 
entry into the staged reconstructive surgery protocol were 
as follows: Fontan operation, 2-ventricle repair, crossover 
to heart transplantation, and death before definitive re- 
pair. Those for the heart transplantation protocol were 
heart transplantation, crossover to a Norwood operation, 
and death while awaiting transplantation. 
Resu l ts  
Morpho logy .  Of  the 323 pat ients  with aort ic  valve 
atresia, 309 pat ients  (96%) had severe  left ventr ic -  
ular hypoplasia.  O f  these, 175 pat ients  had mitra l  
atresia, 117 had a patent  but  stenot ic  or  hypoplast ic  
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mitral valve, and 17 patients had unknown mitral 
valve morphology. Six patients (2%) had a moderate 
degree of left ventricular hypoplasia, nd 8 patients 
(2.5%) had a normal-sized left ventricle. Of these 8 
patients, all but 1 had a nonrestrictive ventricular 
septal defect. In total, there were 13 patients (4%) 
with ventricular septal defects of various sizes. The 
spectrum of cardiac anomalies associated with aortic 
valve atresia is shown in Table I and associated 
noncardiac anomalies in Table II. 
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Survival. For all 323 patients, survival at 1, 3, 12, 
24, and 36 months after entry was 63%, 55%, 50%, 
48%, and 47%, respectively (Fig. 1, A). The single 
phase of hazard was a rapidly declining one, but an 
appreciable instantaneous risk of death was still 
present 12 months after entry (Fig. 1, B). As stated, 
numerous patient factors, protocol or procedure 
factors, and experience factors were used in multi- 
variable analyses to identify risk factors for (corre- 
lates of) death at any time after entry. Among 
demographic and morphologic factors, those identi- 
fied as risk factors for death at any time after entry 
include lower birth weight (/9 = .04), nonwhite race 
(P - .02), and the presence of an associated non- 
cardiac anomaly (P = .007). None of the features of 
cardiac morphology analyzed, including ascending 
aortic size, degree of left ventricular hypoplasia, nd 
degree of mitral hypoplasia or atresia, were predic- 
tive of survival° 
Of the 21 participating institutions, 9 institutions 
entered patients into more than 1 protocol, includ- 
ing 4 institutions that used both surgical treatment 
protocols (Table ITI). A total of 253 patients (78%) 
were entered into a staged reconstructive surgery 
protocol, 49 patients (16%) into a heart transplan- 
tation protocol, and 21 patients (7%) into a nonsur- 
gical protocol. There were a total of 10 crossovers, 
including 3 patients from the nonsurgical protocol 
into either the staged reconstructive surgery (n = 2) 
or transplantation (  -- 1) protocol. All 3 of these 
patients were alive at most recent follow-up. Fig. 2 
depicts schematically the fate of the 323 patients 
after initial protocol assignment. 
In comparing protocols, the likelihood of death at 
any time after entry was higher for patients in the no 
treatment protocol (P < .0001) or the staged recon- 
structive surgery protocol (P = .03) than for those in 
the transplantation protocol. Four institutions were 
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identified as having higher survival than the rest 
(lower risk of death at any time after entry), P < .05. 
Two of these institutions used the staged reconstruc- 
tive surgery protocol and 2 the heart transplantation 
protocol. For the 113 patients treated at these 4 
institutions, survival at 1, 3, 12, 24, and 37 months 
after entry was 77%, 70%, 64%, 62%, and 61%, 
respectively (Fig. 3). 
Staged reconstructive surgery protocol. The 253 
patients entered into a staged reconstructive surgery 
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protocol were distributed among 19 different insti- 
tutions, with 3 institutions accounting for 140 (55%) 
of the patients and with half of the institutions each 
accounting for 5 patients or fewer. Time-related 
survival among the 253 patients entered into the 
staged reconstructive surgery protocol is depicted in 
Fig. 4, A. The hazard function for death has only a 
single declining phase with a sharp change in the 
rate of decline (inflection) at about 4 months after 
entry (Fig. 4, B). For patients entered into the 
staged reconstructive surgery protocol, incremental 
risk factors for death at any time after entry (mul- 
tivariable analysis) include lower birth weight and 
associated noncardiac anomalies. More recent date 
of entry tended to be associated with a higher isk of 
mortality (P = .09). Two institutions were identified 
as negative risk factors for death at any time after 
entry. However at each of these 2 low-risk institu- 
tions, more recent date of admission was associated 
with a higher risk of mortality (P < .05). 
Of patients managed initially with a first-stage 
Norwood procedure, 121 patients have subsequently 
undergone a superior vena cava-pulmonary artery 
anastomosis (bidirectional Glenn or hemi-Fontan 
procedure) at a median age of 6.4 months. Thirty- 
eight have thus far undergone a completion Fontan 
operation at a median age of 20 months. Fig. 5 
depicts a Competing Risks Analysis of the various 
events after initial enrollment in the staged recon- 
structive surgery protocol. 
Transplantation protocol. The 49 patients en- 
tered into a heart transplantation protocol were 
distributed among 6 different institutions, with 3 
institutions accounting for 45 (92%) of the pa- 
tients. Time-related survival among the 49 pa- 
tients entered into a heart transplantation proto- 
col is depicted in Fig. 6, A. The hazard function 
for death has only a single declining phase with a 
change in the rate of decline (inflection) at 4 to 5 
months (Fig. 6, B). For patients entered into the 
heart transplantation protocol, incremental risk 
factors for death at any time after entry included 
lower birth weight and nonwhite race. Of the 3 
institutions accounting for most of the patients in 
the heart transplantation protocol, 2 were identi- 
fied as having higher survivals for patients in the 
heart transplantation protocol than the others. 
These 2 centers together accounted for 34 pa- 
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tients in the heart transplantation protocol and 
for 5 patients in the nonsurgical protocol. 
Of the total of 49 patients initially entered into 
the heart transplantation protocol, 36 underwent 
heart transplantation. Four patients crossed over to 
reconstructive surgery and underwent a first-stage 
Norwood procedure (with 2 survivors) and 1 was 
removed from the transplant list and died. Eight 
others died awaiting transplantation. Fig. 7 depicts a 
Competing Risks Analysis of the various events 
after initial enrollment in the heart transplantation 
protocol. That the altered natural history of patients 
receiving supportive care in anticipation of eventual 
transplantation is markedly different from the natu- 
ral history of the disease itself is illustrated in Fig. 8, 
depicting non-risk-adjusted survival of patients 
awaiting transplantation a d of those in the nonsur- 
gical treatment protocol. 
Protocol comparisons. Non-risk-adjusted sur- 
vival at any time after entlT was higher for patients 
in the heart transplantation protocol than for those 
in the staged reconstructive surgery protocol (Fig. 
9). Time-related survival was by far lowest in the 
nonsurgical protocol, with all survival accounted for 
by protocol crossovers. 
Each of the 4 low-risk institutions made virtually 
exclusive use of one or the other of the 2 surgical 
treatment protocols. Three of the 4 institutions 
also entered a total of 5 patients into a nonsurgi- 
cal treatment protocol. To characterize the out- 
come of surgical treatment at a low-risk institution, 
and to determine whether an optimal treatment 
protocol could be identified, the survival of pa- 
tients managed in the respective surgical treat- 
ment protocols at these 4 institutions was com- 
pared (Fig. 10, A). Despite the use of the 2 
different surgical protocols, the difference in sur- 
vival statistics among the 4 institutions was not 
more than could be due to chance alone (P - .1 ), 
with 70% confidence limits converging at an in- 
terval of approximately 1 week after entry. Sur- 
vival at 1, 3, 12, 24, and 36 months after entry was 
77%, 70%, 64%, 62%, and 62%, respectively, for 
patients treated at the 4 tow-risk institutions. 
These results using the 2 treatment protocols at 
the 4 low-risk institutions are also compared with 
corresponding results at the remainder of the 
institutions (Fig. 10, B). 
Discussion 
Critique of the study. This study has the advan- 
tage of having enrolled 323 neonates with a single 
diagnosis in 3 years (enrollment and annual fol- 
low-up continue). Most of the previous studies 
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patients remaining at risk at the time of estimate. The solid lines are the parametric estimates of survival, 
and the dashed lines enclose the 70% confidence intervals. 
originating from individual institutions report the 
results of treatment of considerably smaller pa- 
tient groups. Among those institutions having 
reported on experience with large volumes of 
patients, virtually all have contributed to this 
multi-institutional study. 12-16 The majority of pre- 
vious reports focus on the outcome of a particular 
operative strategy (ie, either the Norwood opera- 
tion or orthotopic heart transplantation) and, in 
most instances, are reflective of the management 
of a heterogeneous patient group in that they 
describe the management and outcomes of pa- 
tients with hypoplastic left heart syndrome or 
lesions resembling this syndrome. By limiting the 
analysis to those patients with aortic valve atresia, 
we have hoped to shed light on the influence of 
treatment strategy on a more anatomically and 
physiologically homogeneous patient population. 
Nevertheless, the study has limitations. No at- 
tempt was made to prospectively randomize man- 
agement protocols. As such, the selection of pro- 
tocols and therefore the inferences that can be 
made concerning results may to some extent still 
be influenced by individual institutional biases. 
Study design did not enable us to ascertain 
whether there are anatomic, morphologic, or other 
patient characteristics which for this specific cardiac 
anomaly would mitigate for a higher likelihood of 
survival with one or the other of the surgical treat- 
ment strategies. It has been speculated, for example, 
that this may be true with regard to either severe 
tricuspid valve incompetence or pulmonary venous 
obstruction resulting from intact atrial septum or 
anomalies of pulmonary venous return. Although 
these last 2 were among the associated cardiac 
anomalies included in the multivariable analyses, 
their relatively low prevalence together with the 
overall mortality of approximately 50% may have 
led to an underestimate of their potential impor- 
tance. 
The study is also limited by our current inability to 
identify and analyze any late-phase vents associ- 
ated with either of the treatment strategies. Cer- 
tainly a consideration of the late-phase vents after 
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Fig. 10. A, Non-risk-adjusted survival of patients entered into treatment protocols at the 4 low-risk 
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creation of the Fontan-type circulation (eg, ventric- 
ular dysfunction, arrhythmias, protein-losing enter- 
opathy) and those after transplantation (eg, late 
rejection, lymphoproliferative disease, graft athero- 
sclerosis) is essential to the overall comparisml of 
surgical treatment strategies for aortic atresia. Ad- 
ditionally, the majority of patients enrolled in the 
reconstructive surgical protocol have yet to undergo 
a definitive repair (Fontan operation), although to 
date mortality for the second- and third-stage pro* 
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cedures has been low. It should be possible, after a 
longer period of follow-up of this patient cohort, to 
know more about the relative efficacy of treatment 
strategies. 
Inferences as to therapy. For neonates with aor- 
tic atresia, supportive medical therapy (as applied in 
anticipation of transplantation as initial and defini- 
tive therapy) results in a drastic alteration of the 
adverse natural history associated with the lesion 
itself. As such, it is possible that the application of 
the same principles of supportive therapy to all 
patients in anticipation of either transplantation or 
palliative reconstructive surgery might favorably af- 
fect overall survival. Although the interval between 
entry and procedure was among those factors ana- 
lyzed in the multivariable analyses and was not 
found to be predictive of survival, 75% of the 
patients who underwent a Norwood operation did 
so by 8 days of age, whereas the median age for 
heart transplantation was 1.9 months. The experi- 
ence of the transplant centers is supportive of the 
inference that the majority of patients can be suc- 
cessfully stabilized and supported for a period of 
time, obviating the necessity for early emergency 
surgery in most instances. It would be of interest o 
explore the hypothesis that an additional period of 
medical stabilization and supportive therapy might 
favorably affect the outcome of initial palliative 
reconstructive surgery. 
It was not uniformly the case that every high- 
volume center was among the low-risk institutions. 
At the same time, the nearly exclusive use of one or 
the other of the 2 surgical treatment protocols at 
each of the 4 low-risk institutions suggests that a 
strong institutional commitment to a particular ther- 
apeutic strategy is a principal ingredient of interme- 
diate-term success. At the present time, survival of 
neonates with aortic atresia managed by either of 
the 2 surgical treatment protocols at a low-risk 
institution is slightly greater than 60% at 2 years. 
This is not importantly lower than the likelihood of 
survival for patients with some of the other challeng- 
ing congenital heart malformations that require 
initial surgical interventions during the newborn 
period.17, 18 This study was intentionally limited to 
an examination of survival after initial neonatal 
management of aortic atresia. Additional follow-up 
and further analyses of this relatively large patient 
group may further enhance our ability to optimize 
the medical and surgical management of patients 
with this challenging cardiac malformation. 
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Appendix A 
The 21 institutions, in randomly determined order, 
participating in this study of the Congenital Heart Sur- 
geons Society. 
Mott Children's Hospital, Ann Arbor, MI; The Univer- 
sity of Alabama at Birmingham, Birmingham, AL; The 
Children's Hospital, Boston, MA; The Children's Hospital 
of Buffalo, Buffalo, NY; Children's Memorial Hospital, 
Chicago, IL; The University of Chicago, Chicago, IL; 
Children's Hospital Medical Center, Cincinnati, OH; The 
Children's Hospital, Denver, CO; The Children's Hospital 
of Michigan, Detroit, MI; Duke University Medical Cen- 
ter, Durham, NC; The Milton S. Hershey Medical Center, 
Hershey, PA; Loma Linda University Medical Center, 
Loma Linda, CA; The Children's Hospital of Los Angeles, 
Los Angeles, CA; Jackson Memorial Hospital, Miami, FL; 
Columbia-Presbyterian Medical Center, New York, NY; 
The Children's Memorial Hospital, Omaha, NB; The 
Children's Hospital of Philadelphia, Philadelphia, PA; 
Appendix B2. Aortic valve atresia (CHSS; 1994 to 
1997; n = 323): Incremental risk ,factors for death at 
any time after entry, entering patient-specific 
variables" only 
Incremental risk factors for death 
after entry: Patient Jactors only 
Single hazard phase 
Coefficient ++_ SD P value 
Patient 
Birth weight* (lower) -0.0526 _+ 0.025 .04 
African American or Hispanic 0.494 _+ 0.20 .02 
ethnicity 
Left superior vena cava 0.541 + 0.31 .08 
Associated noncardiac anomaly 0.728 _+ 0.27 .007 
Intercept 0.270 
6 = 0, p 0.390, v - 1.83, in - -  0. 
*(Birth weight [kg]) 2 squared transformation. 
University of Pittsburgh Children's Hospital, Pittsburgh, 
PA; The Mayo Clinic, Rochester, MN; The Hospital for 
Sick Children, Toronto, ON, Canada; Georgetown Uni- 
versity Medical Center, Washington, DC. 
Appendix B1. Aortic valve atresia (CHSS; 1994 to 
1997; n = 323): Variables used in the multivariable 
analyses 
Patient 
Dern%q'aphic: Age (days) at entry, gestation (weeks), birth 
weight (kg), gender (male, female), race (white, African- 
American, Hispanic, other), weight at ent131 (kg), height at 
entry (cm), body surface area at entry (mr), prenatal diagno- 
sis 
Molphologic: Mitral stenosis (vs atresia), size (Z-value) of 
ascending aorta, left ventricular-coronary artery fistulas, 
presence and size of ventricular septal defect, anomalous 
origin of right subclavian artery, anomalous pulmonary ve- 
nous connection, intact atrial septum, important noncardiac 
congenital anomaly 
Management: Treatment protocol determined at entry (in- 
tent-to-treat) 
Experience 
Date of entry, individual institution identifier, individual sur- 
geon identifier 
Procedure (when time zero is the time of an operation) 
Demographic: Age at procedure, interval between entry and 
procedure, interval between listing and transplantation (for 
heart transplantation) 
Norwood operation: More-or-less classic Norwood, modified 
Norwood (augmentation with descending aorta, end-to-end 
aorta-pulmonary artery anastomosis with ascending aortic 
implant), size of systemic-puhnonary shunt (in mm, and nor- 
malized to body surface area and weight) 
Support: Total circulatory arrest time (rain), myocardial isch- 
emic time (min) (includes torage time for transplanted 
hearts) 
Surgical experience (when time zero is the time of an opera- 
tion) 
Date of procedure, individual institution identifier, individual 
surgeon identifier 
Appendix B3. Aortic valve atresia (CHSS," 1994 to 
1997," n = 323)." Incremental risk.factors ,for death at 
any time after entry, entering protocol factors only 
(above) and patient and protocol factors (below) 
Incremental risk factors for 
death after entry: Protocols only 
Single hazard phase 
Coefficient ± SD P value 
Protocol 
No treamaent protocol 1.87 ± 0.34 <.000I 
Staged reconstructive surgery 0.539 ± 0.25 .03 
protocol 
Intercept -0.740 
6 -  0, p -  0.397, v -  1.81, m-  0. 
Incremental risk factors for 
death after entry: Patient and 
protocol fi4ctors 
Single hazard phase 
Coefficient ++_ SD P value 
Patient 
Birth weight* (lower) 0.0577 _+. 0.025 
African American or His- 0.483 ± 0.21 
panic ethnicity 
Left ventricle-coronary ar- 0.876 ± 0.46 
tery fistulas 
Left superior vena cava 0.538 ± 0.32 
Associated noncardiac anom- 0.533 _+_ 0.27 
aty 
Protocol 
No treatmcnt protocol 1.83 + 0.34 
Staged reconstructive surgery 0.629 + 0.26 
protocol 
Intercept - 0.234 
6 0, p 0.436, v = t.85, m - 0. 
*(Birth weight [kg]) 2 squared transformation. 
.02 
.02 
.06 
.09 
.05 
<.0001 
.01 
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Append ix  B4 .  Aortic valve atresia (CHSS; 1994 to 1997," n = 323)." Incremental risk factors for death at any 
time after entry, entering patient-related factors, protocol factors, and experience factors 
incremental risk .factors .for death after entry: 
Patient, protocol, and experience .factors 
Single hazard phase 
Coejficient +_ SD P value 
Patient 
Birth weight* (lower) -0.0595 _+ 0.026 .02 
African American or Hispanic ethnicity 0.707 + 0.21 .0008 
Left ventricle-coronary artery fistulas 0.984 + 0.47 .04 
Left superior vena cava 0.603 -+ 0.32 .06 
Associated noncardiac anomaly 0.933 -+ 0.28 .0009 
Protocol 
No treatment protocol 2.06 + 0.36 <.0001 
Staged reconstructive surgery protocol 1.12 + 0.30 .0002 
Experience 
Institution E 0.995 +_ 0.40 .01 
Institution N -0.937 _+ 0.36 .009 
And (later) date of admissiont 0.154 ± 0.074 .04 
Institution R -0.946 ± 0.53 .07 
And (later) date of admission 0.603 _+ 0.26 .02 
Intercept - 0.590 
6 -  0, p -  0.502, ~-  1.91, m-0 .  
*(Birth weight [kg]) 2 squared transformation. 
?(Years since January 1, 1994) 2squared transformation. 
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